secwatch.observer — SEC 8-K summary
======================================

Issuer:     Applied Therapeutics, Inc. (—)
CIK:        0001697532
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001193125-26-034559
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied Therapeutics acquired by Cycle Group Holdings for ~$14.3M; shares delisted from Nasdaq
--------------------------------------------------------------------------------

- Tender offer closed with 79.5M shares (51.56%) tendered; Purchaser accepted all; merger completed Feb 3, 2026.
- Aggregate consideration approx. $14.3M, consisting of $0.088/share plus one CVR per share (up to $0.40 plus pro rata closing cash).
- All directors and officers resigned; James Harrison named President and sole director; Andrea Reiner Secretary.
- Shares to be delisted from Nasdaq; company will file Form 15 to suspend SEC reporting obligations.
- Outstanding stock options and RSUs cashed out or cancelled per merger terms; warrants treated based on type.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697532/000119312526034559/0001193125-26-034559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697532/000119312526034559/d93556d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-034559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer